| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029990219 |
| P356 | DOI | 10.1038/SJ.ONC.1208925 |
| P698 | PubMed publication ID | 16123805 |
| P5875 | ResearchGate publication ID | 7636504 |
| P2093 | author name string | Bibhuti Mishra | |
| Nady Golestaneh | |||
| P2860 | cites work | TGF-beta signal transduction | Q22003891 |
| Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues | Q24291372 | ||
| Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton | Q24317739 | ||
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Cancerous stem cells can arise from pediatric brain tumors | Q24569653 | ||
| Mutations in beta-spectrin disrupt axon outgrowth and sarcomere structure | Q24670180 | ||
| A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells | Q24682602 | ||
| Transforming growth factor-beta and breast cancer: Mammary gland development | Q24793194 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor function | Q28119050 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| TGFbeta signaling in growth control, cancer, and heritable disorders | Q28142605 | ||
| Caenorhabditis elegans beta-G spectrin is dispensable for establishment of epithelial polarity, but essential for muscular and neuronal function | Q28144432 | ||
| Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice | Q28204809 | ||
| Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
| Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma | Q55480552 | ||
| Effects of transforming growth factor-beta 1 on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. | Q55481000 | ||
| Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system | Q62003162 | ||
| Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation | Q70104566 | ||
| Spectrin-actin interaction is required for neurite extension in NB 2a/dl neuroblastoma cells | Q71453970 | ||
| The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain | Q71674757 | ||
| Spectrin (betaSpIIsigma1) is an essential component of synaptic transmission | Q73416448 | ||
| Cell contact regulates fate choice by cortical stem cells | Q73770837 | ||
| Neurogenesis in the adult brain | Q77590734 | ||
| Coordinate regulation of neural tube patterning and proliferation by TGFbeta and WNT activity | Q80600430 | ||
| The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
| Mads and Smads in TGF beta signalling | Q28268871 | ||
| Bone morphogenetic proteins | Q28300236 | ||
| Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. | Q28505355 | ||
| Calcineurin initiates smooth muscle differentiation in neural crest stem cells | Q28567197 | ||
| SOX10 Maintains Multipotency and Inhibits Neuronal Differentiation of Neural Crest Stem Cells | Q28579735 | ||
| Mammalian neural stem cells | Q29547657 | ||
| NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
| Applying the principles of stem-cell biology to cancer | Q29622827 | ||
| Elf3 encodes a novel 200-kD beta-spectrin: role in liver development. | Q31917712 | ||
| Chromosomal location of three spectrin genes: relationship to the inherited hemolytic anemias of mouse and man. | Q33663176 | ||
| TGF-beta and cancer. | Q33804136 | ||
| Regulation of Smad activity | Q33830190 | ||
| TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development | Q33834762 | ||
| Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome | Q33915737 | ||
| EGF mutant receptor vIII as a molecular target in cancer therapy | Q33950534 | ||
| The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions | Q34083587 | ||
| Somatostatin receptors in gliomas | Q34087768 | ||
| Neurogenesis in the adult brain: death of a dogma | Q34185490 | ||
| Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis | Q34199848 | ||
| Stem cells and pattern formation in the nervous system: the possible versus the actual | Q34245281 | ||
| Stem cell plasticity--building the brain of our dreams | Q34297145 | ||
| Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells | Q34340548 | ||
| Differential modulation of BMP signaling promotes the elaboration of cerebral cortical GABAergic neurons or oligodendrocytes from a common sonic hedgehog-responsive ventral forebrain progenitor species | Q34416047 | ||
| Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations | Q34425181 | ||
| Neural induction, the default model and embryonic stem cells | Q34609912 | ||
| Gli and hedgehog in cancer: tumours, embryos and stem cells. | Q34665999 | ||
| Plasticity, niches, and the use of stem cells | Q34682565 | ||
| The control of neural stem cells by morphogenic signals | Q34723662 | ||
| Sequential actions of BMP receptors control neural precursor cell production and fate | Q35080582 | ||
| TGF-beta receptors | Q35230820 | ||
| Cerebellar granule cell precursors can differentiate into astroglial cells | Q36017309 | ||
| Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1 | Q36080037 | ||
| Fodrin: axonally transported polypeptides associated with the internal periphery of many cells | Q36205287 | ||
| Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells | Q36215178 | ||
| Dynamics of membrane-skeleton (fodrin) organization during development of polarity in Madin-Darby canine kidney epithelial cells | Q36215802 | ||
| Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition | Q36236062 | ||
| BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells | Q36323531 | ||
| Drosophila beta spectrin functions independently of alpha spectrin to polarize the Na,K ATPase in epithelial cells | Q36327632 | ||
| Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation | Q36531251 | ||
| Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma | Q38289364 | ||
| Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. | Q38332120 | ||
| Composition and expression of spectrin-based membrane skeletons in non-erythroid cells | Q38535426 | ||
| RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. | Q40474790 | ||
| Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). | Q40494554 | ||
| Isolation of cystatin C via functional cloning of astrocyte differentiation factors | Q40498948 | ||
| Brain spectrin: of mice and men. | Q40530033 | ||
| TGF-beta-receptor-mediated signaling | Q40586281 | ||
| Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling | Q40589715 | ||
| Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex | Q40723396 | ||
| Upregulation of acetylcholine synthesis by bone morphogenetic protein 9 in a murine septal cell line. | Q40760995 | ||
| Transforming growth factor-beta in neural embryogenesis and neoplasia | Q40853926 | ||
| Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). | Q40883581 | ||
| Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors | Q41062429 | ||
| The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function | Q41119639 | ||
| TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis | Q41158628 | ||
| TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 | ||
| Regulation of differentiation by TGF-beta | Q41239396 | ||
| Regulatory mechanisms in stem cell biology | Q41352398 | ||
| Growth factor action in neural crest cell diversification | Q41693184 | ||
| Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells | Q42502856 | ||
| Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor | Q43790233 | ||
| ELF a beta-spectrin is a neuronal precursor cell marker in developing mammalian brain; structure and organization of the elf/beta-G spectrin gene | Q44083886 | ||
| Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. | Q44189620 | ||
| Multilineage differentiation of ectomesenchymal cells isolated from the first branchial arch | Q45180215 | ||
| Context-dependent neuronal differentiation and germ layer induction of Smad4-/- and Cripto-/- embryonic stem cells. | Q45287445 | ||
| TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice | Q45345227 | ||
| Molecular signals regulating proliferation of stem and progenitor cells in mouse olfactory epithelium | Q46660110 | ||
| Cyclin-dependent kinases regulate the antiproliferative function of Smads | Q47229633 | ||
| Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. | Q47852627 | ||
| Characterization of multipotent adult stem cells from the skin: transforming growth factor-beta (TGF-beta) facilitates cell growth. | Q47858206 | ||
| Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin | Q48008995 | ||
| Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain | Q48110101 | ||
| TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis | Q48125390 | ||
| Distribution of transforming growth factor-beta 1 in human astrocytomas | Q48413669 | ||
| The effect of synapsin I phosphorylation upon binding of synaptic vesicles to spectrin | Q48683754 | ||
| Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas | Q48864528 | ||
| Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin | Q48898258 | ||
| Neural inhibition by c-Jun as a synergizing factor in bone morphogenetic protein 4 signaling. | Q52121876 | ||
| TGF-beta: 20 years and counting. | Q53534770 | ||
| Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor. | Q55478756 | ||
| Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. | Q55478796 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5722-5730 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | TGF-beta, neuronal stem cells and glioblastoma | |
| P478 | volume | 24 |
| Q34554512 | A Cell-Surface Membrane Protein Signature for Glioblastoma |
| Q42113451 | A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma |
| Q52646455 | A highlight on Sonic hedgehog pathway. |
| Q37829652 | Aberrant signaling pathways in medulloblastomas: a stem cell connection |
| Q36962800 | Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression |
| Q38947906 | Androgen receptor signaling regulates growth of glioblastoma multiforme in men. |
| Q40199613 | Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. |
| Q48148598 | Developmentally regulated signaling pathways in glioma invasion. |
| Q89978140 | Diversity of Clinically Relevant Outcomes Resulting from Hypofractionated Radiation in Human Glioma Stem Cells Mirrors Distinct Patterns of Transcriptomic Changes |
| Q34341998 | Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes |
| Q37132697 | Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence. |
| Q54610045 | Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. |
| Q37602543 | Glioblastoma Multiforme Oncogenomics and Signaling Pathways |
| Q39274573 | Growth factors from tumor microenvironment possibly promote the proliferation of glioblastoma-derived stem-like cells in vitro. |
| Q38264460 | HMGA proteins as modulators of chromatin structure during transcriptional activation. |
| Q42031458 | Human stem/progenitor cells from bone marrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor β and Notch signaling |
| Q34633696 | Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. |
| Q30452219 | Improving the Radiosensitivity of Radioresistant and Hypoxic Glioblastoma |
| Q58116685 | Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4 |
| Q47228668 | Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men. |
| Q37949680 | Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. |
| Q46664876 | Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. |
| Q48521240 | Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma |
| Q37495105 | Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists |
| Q38687563 | Role of chitinase-like proteins in cancer. |
| Q39201247 | Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro. |
| Q37760038 | TGFbeta signalling: a complex web in cancer progression |
| Q38438861 | TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme |
| Q27005807 | The potential origin of glioblastoma initiating cells |
| Q40047888 | Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. |
| Q38469127 | Transforming growth factor β and bone morphogenetic protein actions in brain tumors |
| Q35293772 | miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma |
Search more.